SHPH
Shuttle Pharmaceuticals Holdings, Inc.
NASDAQ · USHealthcareDrug Manufacturers - Specialty & Generic
$3.03-4.11%
Price as of Jul 20, 2026
SHPH financials
Shuttle Pharmaceuticals Holdings, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of revenue | $0.00 | $0.00 | $0.00 | $6.0K |
| Gross profit | $0.00 | $0.00 | $0.00 | -$6.0K |
| Operating expenses | $11.9M | $7.7M | $5.9M | $2.3M |
| Operating income | -$11.9M | -$7.7M | -$5.9M | -$2.3M |
| Net income | -$11.7M | -$9.1M | -$6.6M | -$5.0M |
| EBITDA | -$11.4M | -$7.8M | -$4.0M | -$4.3M |
| Basic EPS | $-71.60 | $-8857.30 | $-4.10 | $-3.00 |
| Diluted EPS | $-71.60 | $-8857.30 | $-4.10 | $-3.00 |
| Balance sheet | ||||
| Cash & equivalents | $334.0K | $1.9M | $2.6M | $8.4M |
| Total assets | $10.5M | $2.5M | $6.0M | $8.7M |
| Total liabilities | $8.2M | $1.8M | $1.9M | $975.7K |
| Stockholders’ equity | $2.3M | $709.2K | $4.1M | $7.7M |
| Total debt | $232.1K | $1.2M | $1.1M | $748.3K |
| Net debt | -$101.9K | -$746.7K | -$1.5M | -$7.7M |
| Cash flow | ||||
| Operating cash flow | -$9.5M | -$7.3M | -$5.6M | -$2.7M |
| Capital expenditure | $5.00 | $0.00 | -$19.0K | $0.00 |
| Free cash flow | -$9.5M | -$7.3M | -$5.6M | -$2.7M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | $0.00 | $0.00 | $0.00 | $0.00 |